Top Markets
Coin of the day
Clover Biopharmaceuticals, Ltd. Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd.

2197
Rang in Aktien #15712
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on... Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Aktienkurs
$0.25841098
Marktkapitalisierung
$335.38M
Veränderung (1 Tag)
-2.42%
Veränderung (1 Jahr)
73.70%
Land
CN
Handel Clover Biopharmaceuticals, Ltd. (2197)

Kategorie

Kursverlauf für Clover Biopharmaceuticals, Ltd. (2197)
Höchster Schlusskurs: $0.26 am 2026-09-01

Niedrigster Schlusskurs: $1.43 am 2021-11-01
Kursverlauf der Aktie von Clover Biopharmaceuticals, Ltd. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.59%
2025 858.49%
2024 -56.65%
2023 -82.45%
2022 -72.65%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$549.03 40.41%
US
$1.02K 43.76%
NL
$147.18 510.96%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH